GlassScriptPhysician profile
Jessica A Hicks
NPI 1407167869
$927.14
in general payments reported to CMS, 2019-2025
19 companies · $90.22 in 2025
The $90.22 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $90.74 · 2021: $106 · 2022: $182 · 2023: $166 · 2024: $186 · 2025: $90.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $140.09 | 2020-2025 | Grafix Pl, Oasis, Collagenase Santyl |
| Tactile Systems Technology INC | $110.22 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $93.09 | 2023 | |
| Organogenesis INC. | $77.91 | 2021-2025 | Affinity |
| Urgo Medical North America, LLC | $73.66 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Kci USA, INC. | $66.04 | 2019-2022 | |
| Kerecis Limited | $55.37 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $45.85 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $39.35 | 2019 | |
| Hartmann USA, INC. | $35.66 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $27.62 | 2024 | Nuzyra |
| Reprise Biomedical, INC. | $26.60 | 2024 | Miro3d |
| Organon LLC | $26.00 | 2024 | |
| Aroa Biosurgery Incorporated | $24.21 | 2019-2023 | |
| Solventum Corporation | $21.28 | 2025 | Activ.A.C., V.A.C. Dermatac |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.01 | 2023 | |
| Sanara Medtech INC. | $17.26 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.87 | 2024 | Xifaxan, Trulance |
| Osiris Therapeutics INC. | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.